Your browser doesn't support javascript.
loading
The lncRNA ALPHA specifically targets chikungunya virus to control infection.
Basavappa, Megha G; Ferretti, Max; Dittmar, Mark; Stoute, Julian; Sullivan, Megan C; Whig, Kanupriya; Shen, Hui; Liu, Kathy Fange; Schultz, David C; Beiting, Daniel P; Lynch, Kristen W; Henao-Mejia, Jorge; Cherry, Sara.
Afiliação
  • Basavappa MG; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Ferretti M; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Dittmar M; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Stoute J; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Sullivan MC; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Whig K; Institute for Immunology, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA; High-Throughput Screening Core, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Shen H; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Liu KF; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Schultz DC; Institute for Immunology, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA; High-Throughput Screening Core, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Beiting DP; Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Lynch KW; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Henao-Mejia J; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, University of Pennsylvania, Philadelphia, PA 19104, USA; Division of Protective Immunity, Department of Pathology and Laboratory Medicine, Children's Hospital of Pennsy
  • Cherry S; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA; High-Throug
Mol Cell ; 82(19): 3729-3744.e10, 2022 10 06.
Article em En | MEDLINE | ID: mdl-36167073
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Vírus Chikungunya / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Vírus Chikungunya / RNA Longo não Codificante Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article